Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,632 | 13,867 | 8,223 | 15,313 | 29,386 |
| Receivables | 13,429 | 21,482 | 22,376 | 14,395 | 7,604 |
| Inventories | 9,086 | 25,465 | 24,679 | 15,467 | 5,973 |
| Income taxes - deferred | 905 | 495 | 500 | 1,073 | 846 |
| Other current assets | 23,944 | 0 | 0 | 283 | 244 |
| TOTAL | $54,996 | $61,309 | $55,778 | $48,414 | $44,753 |
| Non-Current Assets | |||||
| PPE Net | 3,983 | 7,143 | 6,746 | 5,918 | 3,506 |
| Intangibles | 11,153 | 27,403 | 28,212 | 20,293 | 0 |
| Other Non-Current Assets | 21,503 | 44,026 | 37,693 | 32,959 | 34,103 |
| TOTAL | $36,639 | $78,572 | $72,651 | $59,169 | $37,609 |
| Total Assets | $91,635 | $139,881 | $128,429 | $107,584 | $82,362 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21 | 20 | 398 | 699 | 3,894 |
| Accounts payable and accrued liabilities | 3,379 | 6,251 | 6,457 | 5,525 | 3,100 |
| Accrued Expenses | 3,732 | 6,688 | 6,202 | 8,513 | 4,355 |
| Other current liabilities | 700 | 946 | 459 | 403 | 207 |
| TOTAL | $12,996 | $16,064 | $15,596 | $16,599 | $12,156 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,500 | 16,520 | 12,787 | 400 | 637 |
| Deferred Revenues | 275 | 2,159 | 2,080 | 1,459 | 600 |
| Other Non-Current Liabilities | 888 | 1,433 | 961 | 1,273 | 0 |
| TOTAL | $10,223 | $19,460 | $13,955 | $2,604 | $3,394 |
| Total Liabilities | $23,219 | $35,524 | $29,551 | $19,202 | $15,550 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,049 | 3,041 | 3,016 | 3,003 | 2,676 |
| Common Shares | 351 | 351 | 348 | 347 | 313 |
| Retained earnings | -108,139 | -76,262 | -78,591 | -82,851 | -83,588 |
| Other shareholders' equity | 3,510 | 7,799 | 5,672 | 264 | -2,206 |
| TOTAL | $68,416 | $104,357 | $98,878 | $88,381 | $66,812 |
| Total Liabilities And Equity | $91,635 | $139,881 | $128,429 | $107,584 | $82,362 |